Fr

Canadian-made COVID-19 vaccine begins clinical trials

The vaccine, created by Providence Therapeutics, will be manufactured in Calgary if it is approved by Health Canada.
By: Alison Larabie Chase
January 28, 2021
Photo: Gavin Young/Postmedia
Photo: Gavin Young/Postmedia

Canadian biotech company Providence Therapeutics announced earlier this week that it is ready to send its COVID-19 vaccine into Phase 1 clinical trials. The Canadian-made vaccine uses similar mRNA technology as the Pfizer/BioNTech and Moderna vaccines that have already been approved and begun distribution. Providence is working with Northern RNA, another Calgary-based firm, to build a facility in that city to produce the vaccine here in Canada, rather than outsourcing production elsewhere.

Brad Sorenson, founder of Providence, says they are “very confident we’re going to have a good vaccine,” based on years of working with mRNA technology, and adds that they are seeking more funding support from the federal government to ramp up production quickly once it begins. Though their vaccine is unlikely to be ready until early 2022, given the distribution difficulties and shortages that have already occurred with the two approved vaccines, the company is confident there will still be a need for it, given that we can't go back to "normal" until approximately six billion people are vaccinated worldwide. Truly, the more vaccines available, the better, so this is a step in the right direction.

Source: Calgary Herald

Tags
InformationalInnovation

Related

What if you could eat the cure?
8 months ago

What if you could eat the cure?

A University of Ottawa plant biologist and a senior scientist at The Ottawa Hospital are researching a plant-based, edible vaccine for the novel coronavirus.
Vancouver biotech company contributes key component for COVID-19 vaccine
3 months ago

Vancouver biotech company contributes key component for COVID-19 vaccine

Researchers at Acuitas Therapeutics have been working seven days a week since February to develop the lipid nanoparticle technology that allows the prototype Pfizer vaccine to work.